Sibannac Expands Wellness Portfolio with New Functional Mushroom and Moringa Products
SNNC has more than doubled off its 52-week low of $0.004 on light trading volume (0.3× avg).
Summary
Sibannac, Inc. announced the development and upcoming market launch of new wellness products featuring Reishi and Lion's Mane mushrooms, as well as Moringa. This strategic expansion aims to diversify the company's revenue streams by re-entering the consumer-packaged-goods marketplace with scalable direct-to-consumer offerings. The CEO emphasized the health benefits, scalability, and lack of regulatory challenges for these products, which complement their existing plant-medicine retreats. This move into growing wellness markets is a material step for the micro-cap company, following its recent joint venture announcement. Investors should monitor the product launch and initial sales performance for impact on future financials.
At the time of this announcement, SNNC was trading at $0.02 on OTC in the Life Sciences sector, with a market capitalization of approximately $2.3M. The 52-week trading range was $0.00 to $0.03. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.